Titia Q Ruijs

6PUBLICATIONS
30CO-AUTHORS
Central nervous systemMolecular medicineNeurology and neuromuscular diseasesPharmacogenomicsSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 14, 2026
Transcranial Magnetic Stimulation as a Translational Biomarker in Early-Phase Anti-Seizure Medication Development: A Randomized, Double-Blind, Placebo-Controlled Study in Generalized Epilepsy.

|Dec 09, 2024
Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.

Titia Q Ruijs, Catherine M K E de Cuba, Jules A A C Heuberger

|Mar 20, 2024
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.

Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk

|Oct 25, 2022
Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over study.

Titia Q Ruijs, Ingrid W Koopmans, Marieke L de Kam

|Jun 28, 2022
Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Titia Q Ruijs, Ingrid W Koopmans, Marieke L de Kam

|Jan 14, 2022
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study.

Titia Q Ruijs, Jules A A C Heuberger, Annika A de Goede

Pageof 1

Frequent Collaborators

6 joint publications

Jules A A C Heuberger

6 joint publications

Geert Jan Groeneveld

3 joint publications

Annika A de Goede

3 joint publications

Robert J Doll